These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 29602703)

  • 1. Pertussis in Africa: Findings and recommendations of the Global Pertussis Initiative (GPI).
    Muloiwa R; Wolter N; Mupere E; Tan T; Chitkara AJ; Forsyth KD; von König CW; Hussey G
    Vaccine; 2018 Apr; 36(18):2385-2393. PubMed ID: 29602703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recommendations to control pertussis prioritized relative to economies: A Global Pertussis Initiative update.
    Forsyth KD; Tan T; von König CW; Heininger U; Chitkara AJ; Plotkin S
    Vaccine; 2018 Nov; 36(48):7270-7275. PubMed ID: 30337176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Global Pertussis Initiative: meeting report from the fourth regional roundtable meeting, France, April 14-15, 2010.
    Guiso N; Liese J; Plotkin S
    Hum Vaccin; 2011 Apr; 7(4):481-8. PubMed ID: 21389775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-cell or acellular pertussis vaccination in infancy determines IgG subclass profiles to DTaP booster vaccination.
    van der Lee S; Sanders EAM; Berbers GAM; Buisman AM
    Vaccine; 2018 Jan; 36(2):220-226. PubMed ID: 29199041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pertussis vaccination in mixed markets: Recommendations from the Global Pertussis Initiative.
    Chitkara AJ; Pujadas Ferrer M; Forsyth K; Guiso N; Heininger U; Hozbor DF; Muloiwa R; Tan TQ; Thisyakorn U; Wirsing von König CH
    Int J Infect Dis; 2020 Jul; 96():482-488. PubMed ID: 32413606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pertussis control in the Asia-Pacific region: a report from the Global Pertussis Initiative.
    Forsyth K; Thisyakorn U; von König CH; Tan T; Plotkin S;
    Southeast Asian J Trop Med Public Health; 2012 May; 43(3):699-711. PubMed ID: 23077850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pertussis vaccination: use of acellular pertussis vaccines among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1997 Mar; 46(RR-7):1-25. PubMed ID: 9091780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pertussis immunization in the global pertussis initiative international region: recommended strategies and implementation considerations.
    Forsyth K; Nagai M; Lepetic A; Trindade E
    Pediatr Infect Dis J; 2005 May; 24(5 Suppl):S93-7. PubMed ID: 15876935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced risk of pertussis among persons ever vaccinated with whole cell pertussis vaccine compared to recipients of acellular pertussis vaccines in a large US cohort.
    Witt MA; Arias L; Katz PH; Truong ET; Witt DJ
    Clin Infect Dis; 2013 May; 56(9):1248-54. PubMed ID: 23487373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced risk of pertussis in whole-cell compared to acellular vaccine recipients is not confounded by age or receipt of booster-doses.
    Sheridan SL; Ware RS; Grimwood K; Lambert SB
    Vaccine; 2015 Sep; 33(39):5027-30. PubMed ID: 26297874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The global pertussis initiative: Meeting report from the Regional Latin America Meeting, Costa Rica, 5-6 December, 2008.
    Ulloa-Gutierrez R; Hozbor D; Avila-Aguero ML; Caro J; Wirsing von König CH; Tan T; Plotkin S
    Hum Vaccin; 2010 Nov; 6(11):876-80. PubMed ID: 20980794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience with monocomponent acellular pertussis combination vaccines for infants, children, adolescents and adults--a review of safety, immunogenicity, efficacy and effectiveness studies and 15 years of field experience.
    Thierry-Carstensen B; Dalby T; Stevner MA; Robbins JB; Schneerson R; Trollfors B
    Vaccine; 2013 Oct; 31(45):5178-91. PubMed ID: 23994021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tdap5 vaccine (Covaxis): a review of its use as a single-booster immunization for the prevention of tetanus, diphtheria, and pertussis in children (aged 4 years), adolescents, and adults.
    Scott LJ
    BioDrugs; 2010 Dec; 24(6):387-406. PubMed ID: 21043546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of infant and preschool pertussis vaccinations on memory B-cell responses in children at 4 years of age.
    Hendrikx LH; de Rond LG; Oztürk K; Veenhoven RH; Sanders EA; Berbers GA; Buisman AM
    Vaccine; 2011 Aug; 29(34):5725-30. PubMed ID: 21669247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global Childhood Deaths From Pertussis: A Historical Review.
    Chow MY; Khandaker G; McIntyre P
    Clin Infect Dis; 2016 Dec; 63(suppl 4):S134-S141. PubMed ID: 27838665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Time for booster doses against whooping cough for 10-year-old children].
    Carlsson RM; Ekholm L; Gothefors L; Granström M; Trolin I; Tegnell A
    Lakartidningen; 2005 Aug 29-Sep 4; 102(35):2394-8. PubMed ID: 16184889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization against pertussis in adolescents and adults.
    Esposito S; Principi N;
    Clin Microbiol Infect; 2016 Dec; 22 Suppl 5():S89-S95. PubMed ID: 27130670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whooping cough, twenty years from acellular vaccines introduction.
    Greco D; Esposito S; Tozzi A; Pandolfi E; Icardi G; Giammanco A
    Ann Ig; 2015; 27(2):415-31. PubMed ID: 26051141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of pertussis in the world.
    Galazka A
    World Health Stat Q; 1992; 45(2-3):238-47. PubMed ID: 1462658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re-emergence of pertussis: what are the solutions?
    Libster R; Edwards KM
    Expert Rev Vaccines; 2012 Nov; 11(11):1331-46. PubMed ID: 23249233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.